Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (8,964)	$ (235)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,832	6,047
Stock-based compensation expense	4,517	3,787
Inventory impairments and abandonments	282	3,181
Deferred and other income tax benefit	(7,334)	(4,266)
Write-off of deposit on legacy land investment	2,700	0
Gain on sale of fixed assets	(72)	(820)
Change in allowance for doubtful accounts	(161)	(180)
Equity in income of unconsolidated entities	55	9
Cash distributions of income from unconsolidated entities	6	33
Non-cash loss on extinguishment of debt	3,676	155
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	9,606	(3,044)
Decrease in income tax receivable	4	198
Increase in inventory	(50,031)	(44,328)
Decrease in other assets	3,546	3,446
Decrease in trade accounts payable	(3,884)	(14,983)
Decrease in other liabilities	(31,730)	(8,867)
Net cash used in operating activities	(72,062)	(59,885)
Cash flows from investing activities:
Capital expenditures	(5,677)	(6,017)
Proceeds from sale of fixed assets	74	2,471
Investments in unconsolidated entities	(2,411)	(2,787)
Return of capital from unconsolidated entities	1,621	1,141
Increases in restricted cash	(6,730)	(1,770)
Decreases in restricted cash	6,439	23,392
Net cash (used in) provided by investing activities	(6,684)	16,430
Cash flows from financing activities:
Repayment of debt	(256,207)	(208,221)
Proceeds from issuance of new debt	250,000	137,900
Repayment of borrowings from credit facility	25,000	25,000
Borrowings from credit facility	25,000	25,000
Debt issuance costs	(4,721)	(2,451)
Other financing activities	(388)	(423)
Net cash used in financing activities	(11,316)	(73,195)
Decrease in cash and cash equivalents	(90,062)	(116,650)
Cash and cash equivalents at beginning of period	228,871	251,583
Cash and cash equivalents at end of period	$ 138,809	$ 134,933